Thermo Fisher revenue rises 9% to $12.14 billion, earnings per share up 15%
Thermo Fisher's third-quarter revenue rose 9% to $12.14 billion from $11.12 billion a year earlier. Adjusted earnings per share increased 15% to $6.68.
Key points
- Organic revenue, which excludes acquisitions, divestitures and currency effects, grew 6%.
- Thermo Fisher completed the sale of its microbiology business.
- The company said it would give its updated 2026 forecast during the investor conference call, so the release itself contains no forecast figures.
Profit grows faster than sales
Organic revenue, which excludes acquisitions, divestitures and currency effects, grew 6%. Earnings per share under reporting standards were $4.64, up 9%.
Operating income rose 17% to $2.26 billion, and operating margin widened to 18.6% from 17.4%. Adjusted operating margin reached 24.5% versus 23.3%.
Thermo Fisher revenue, third quarter
Revenue by quarter, $B
Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.
What the company did in the quarter
Thermo Fisher completed the sale of its microbiology business. Together with Mayo Clinic, it launched Precure, an initiative that will combine data from more than one million patient samples with its protein analysis technologies.
Chief executive Marc Casper called it another excellent quarter and said the company is well positioned for a strong 2026.
What the report lacks
The company said it would give its updated 2026 forecast during the investor conference call, so the release itself contains no forecast figures.
What to check next
The fourth-quarter report will show whether organic growth continues and whether operating margin keeps widening.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Thermo Fisher Scientific
A notification in your browser or on your phone when we publish about Thermo Fisher Scientific. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
